Recombinant Saccharomyces cerevisiae Putative Increased Recombination Centers Protein 11 (IRC11) is a protein associated with the yeast Saccharomyces cerevisiae . S. cerevisiae is a widely studied eukaryotic organism, often used as a model in genetics and biology research . The IRC11 protein is tagged as "putative," meaning its function is suggested but not definitively proven through experimentation .
The Saccharomyces cerevisiae RM11-1a genome project aimed to create a reference genome for a natural isolate of S. cerevisiae . This project sequenced the RM11-1a isolate, which was derived from a California vineyard isolate and has distinct characteristics from the standard lab strain S288C . The availability of the RM11-1a sequence allows researchers to identify genetic variations and study wild-type alleles, as well as genetic variation within S. cerevisiae .
IRC11 is related to DNA repair and recombination processes in S. cerevisiae . One study found that Rev7, another protein in S. cerevisiae, interacts with the Mre11-Rad50-Xrs2 (MRX) complex to regulate DNA double-strand break (DSB) repair pathway choice . This interaction influences the balance between homologous recombination (HR) and non-homologous end joining (NHEJ) repair mechanisms .
Research indicates that Rev7 interacts physically with the MRX complex subunits, specifically Mre11, Rad50, and Xrs2 . The C-terminal 42-amino acid fragment of Rev7 is critical for this interaction . This interaction modulates the activity of Mre11 nuclease and Rad50 ATPase, impacting how DSBs are processed and repaired .
Yeast two-hybrid assays have demonstrated binary interactions between Rev7 and the MRX complex subunits . Mutants lacking Rev3 still showed these interactions, indicating that Rev3 is not required for Rev7 binding to the MRX subunits . Additionally, studies using truncated Rev7 variants identified the C-terminal 42-residue segment as essential for interaction with the MRX complex .
STRING: 4932.YOR013W
IRC11 (Putative Increased Recombination Centers Protein 11) is a 156-amino acid protein encoded by the IRC11 gene (YOR013W) in Saccharomyces cerevisiae. While its precise molecular function remains under investigation, it's classified among proteins involved in recombination center regulation based on genetic studies.
IRC11 likely contributes to homologous recombination pathways that are critical for maintaining genomic stability in yeast. Its classification suggests a potential role in regulating recombination frequency, possibly by interacting with known recombination machinery components. The protein's modest size (156 amino acids) suggests it may function as part of a larger complex rather than as an independent enzymatic unit.
IRC11 knockout studies suggest it may function in recombination regulation, though the phenotypes are subtle compared to major recombination factors. Based on current understanding of increased recombination center proteins:
IRC11 deletion likely doesn't compromise cell viability under standard growth conditions, unlike deletion of essential recombination factors (MRE11, RAD50, XRS2)
Deletion may increase recombination frequencies at certain genomic loci
Effects may be more pronounced under genotoxic stress conditions
IRC11 knockout phenotypes likely interact with mutations in other recombination pathway genes
For comprehensive phenotypic assessment, researchers should measure:
Spontaneous recombination rates using reporter systems
Sensitivity to DNA-damaging agents (UV, MMS, hydroxyurea)
Genetic interactions with known recombination mutants
Cell cycle progression under normal and stress conditions
Based on established protocols for recombinant yeast proteins:
Expression system optimization:
E. coli is the preferred expression system (BL21(DE3) strain recommended)
Express as a full-length protein (1-156aa) rather than truncated versions
Optimize induction conditions: 0.5mM IPTG, 16-20°C overnight for improved solubility
Purification protocol:
Harvest cells and lyse in Tris/PBS-based buffer (pH 8.0) containing:
Purify using immobilized metal affinity chromatography (IMAC):
Bind to Ni-NTA resin
Wash with buffer containing 50mM imidazole
Elute with buffer containing 250mM imidazole
Further purification by size exclusion chromatography
Storage recommendations:
Commercial antibodies against IRC11 are available for research applications:
Available antibody specifications:
Polyclonal rabbit antibody against recombinant S. cerevisiae IRC11
Supplied in liquid form in 50% glycerol, 0.01M PBS (pH 7.4) with 0.03% Proclin 300 preservative
Recommended applications:
Western blotting:
Use 1:1000-1:2000 dilution
Confirm using anti-tubulin as loading control
Block with 5% non-fat milk in TBST
ELISA assays:
For quantitative detection of IRC11 in cell lysates
Use standard curves with purified recombinant IRC11
Immunoprecipitation:
For studying protein-protein interactions
Cross-validate findings with reciprocal IP
Immunofluorescence:
Requires additional validation
Fixation optimization may be necessary
While specific IRC11 interaction data is limited, its function can be contextualized within established yeast recombination pathways:
Homologous recombination (HR) connections:
Non-homologous end joining (NHEJ) relation:
Cell cycle checkpoint interactions:
To systematically map IRC11's role:
Perform synthetic genetic array (SGA) analysis with IRC11 deletion
Analyze epistasis relationships with known recombination mutants
Measure recombination rates in double mutants (IRC11 with checkpoint or recombination genes)
Assess IRC11's influence on radiation-induced recombination frequencies
Several complementary approaches can elucidate IRC11's function in DNA repair:
Recombination assays:
DNA damage sensitivity testing:
Microscopy techniques:
Immunofluorescence to track IRC11 localization after DNA damage
Live-cell imaging with fluorescently tagged IRC11
Co-localization studies with known repair factors
Biochemical approaches:
In vitro assays to test potential enzymatic activities
Pull-down experiments to identify interaction partners
ChIP assays to detect genomic binding sites
Example experimental design for damage sensitivity assay:
| Treatment | Wild Type Survival | IRC11Δ Survival | IRC11Δ/RAD51Δ Survival |
|---|---|---|---|
| Control | 100% | 100% | 100% |
| 100 rad X-ray | 85% | [Measure] | [Measure] |
| 200 rad X-ray | 70% | [Measure] | [Measure] |
| 500 rad X-ray | 50% | [Measure] | [Measure] |
| 1000 rad X-ray | 30% | [Measure] | [Measure] |
To quantify IRC11's impact on recombination, several established systems can be employed:
Plasmid-based recombination assays:
Chromosomal recombination reporters:
Radiation-induced recombination measurement:
Quantitative PCR approaches:
Example data presentation format:
| Strain | Spontaneous Recombination | X-ray Induced (2 krad) | Fold Change |
|---|---|---|---|
| Wild-type | 6.0 × 10⁻⁸ | 1.3 × 10⁻⁵ | ~200x |
| IRC11Δ | [Measure] | [Measure] | [Calculate] |
| RAD51Δ | [Measure] | [Measure] | [Calculate] |
| IRC11Δ RAD51Δ | [Measure] | [Measure] | [Calculate] |
To comprehensively characterize IRC11 expression patterns:
Growth condition variations:
Cell cycle analysis:
Synchronize cells using α-factor arrest-release
Collect samples at defined time points throughout the cell cycle
Quantify IRC11 mRNA and protein levels
DNA damage response:
Treat cells with various DNA-damaging agents (MMS, UV, X-rays)
Monitor expression changes using RT-qPCR and Western blot
Track expression kinetics during DNA damage response
Promoter analysis:
Methodological approach for RT-qPCR analysis:
Design primers specific to IRC11 mRNA
Use reference genes like ACT1 for normalization
Present data as fold-change relative to standard conditions
Analyze statistical significance using appropriate tests (ANOVA, t-test)
To map IRC11's functional relationships:
Systematic double knockout analysis:
Quantitative phenotypic analysis:
Epistasis analysis:
Determine whether IRC11 functions upstream, downstream, or in parallel to known pathways
Analyze double and triple mutant phenotypes to establish pathway relationships
Use overexpression studies to complement deletion phenotypes
Research has shown that double mutants defective in both recombination repair genes and checkpoint function exhibit synergistic increases in spontaneous recombination rates . Similar analysis with IRC11 could reveal its pathway position.
Example genetic interaction data presentation:
| Strain Genotype | Growth Rate | Recombination Rate | UV Sensitivity | X-ray Sensitivity |
|---|---|---|---|---|
| Wild-type | 100% | 6.0 × 10⁻⁸ | baseline | baseline |
| IRC11Δ | [measure] | [measure] | [measure] | [measure] |
| RAD51Δ | [measure] | [measure] | [measure] | [measure] |
| RAD9Δ | [measure] | [measure] | [measure] | [measure] |
| IRC11Δ RAD51Δ | [measure] | [measure] | [measure] | [measure] |
| IRC11Δ RAD9Δ | [measure] | [measure] | [measure] | [measure] |
To understand IRC11's evolutionary context:
Homology identification:
Perform BLAST searches against fungal genomes
Conduct phylogenetic analysis of IRC family proteins across yeast species
Use more sensitive profile-based searches (HMM) for distant homologs
Functional complementation:
Express putative homologs in S. cerevisiae IRC11Δ strains
Test if homologs rescue IRC11 deletion phenotypes
Analyze domain conservation and functional motifs
Comparative genomics:
Evolutionary rate analysis:
Methodological considerations:
For distant homologs, focus on structural similarity rather than sequence identity
Consider synteny (conservation of chromosomal context) as evidence for orthology
Test multiple alignment algorithms to improve homology detection
Use protein structure prediction to identify functional conservation despite sequence divergence
Researchers may encounter contradictory results when studying IRC11. Strategies to address such conflicts include:
Experimental variability assessment:
Strain background considerations:
Growth condition standardization:
Statistical rigor:
As noted in studies of other yeast genes, "although often significant from a statistical viewpoint due to the huge number of microcolonies that were analyzed, the differences that fluctuate sometimes in one direction and sometimes in the other [...] suggest that the initial expression level in a cell does not influence the subsequent growth rate" . Similar challenges may apply to IRC11 research.
Emerging technologies offer new opportunities to characterize IRC11:
Proteomics approaches:
BioID or APEX proximity labeling to identify interaction partners in vivo
Crosslinking mass spectrometry (XL-MS) to map protein interaction interfaces
Hydrogen-deuterium exchange mass spectrometry for structural dynamics
High-resolution microscopy:
Super-resolution microscopy to visualize IRC11 localization at recombination centers
Single-molecule tracking to monitor IRC11 dynamics during recombination
FRET-based approaches to detect protein-protein interactions in living cells
Genomics methods:
ChIP-seq to identify IRC11 binding sites genome-wide
CUT&RUN for higher resolution binding profiles
HiChIP to detect long-range chromatin interactions mediated by IRC11
CRISPR-based approaches:
CRISPRi for tunable repression of IRC11 expression
CRISPR activation to study overexpression effects
Base editing to introduce specific mutations without DSB formation
IRC11 research has implications beyond basic yeast biology:
Model system advantages:
Translational relevance:
Understanding recombination regulation has implications for genomic instability in cancer
Recombination proteins are potential therapeutic targets
Insights from yeast homologs inform human disease mechanisms
Biotechnology applications:
Improved yeast strains with optimized recombination properties for genetic engineering
Enhanced homologous recombination for gene targeting applications
Exploitation of yeast recombination for synthetic biology applications
Evolutionary insights:
How recombination center proteins evolved to maintain genomic stability
Relationship between environmental adaptation and recombination regulation
Role of recombination in yeast population genetics and speciation